Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2020 | Genomic alterations in solid tumors according to ESCAT

Patricia Martin Romano • 21 Sep 2020
ESMO 2020
Gastrointestinal Cancer General Lung Cancer Non-Small Cell Lung Cancer

Patricia Martin Romano, MD, MSc, PhD, Gustave Roussy, Saclay University of Paris, Villejuif, France, discusses genomic alterations in solid tumors according to ESMO scale for clinical actionability of molecular targets (ESCAT). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Related Videos

2:45
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao • 18 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals